期刊文献+

原发性中枢神经系统淋巴瘤的治疗 被引量:3

Treatment of primary central nervous system lymphoma
原文传递
导出
摘要 原发性中枢神经系统淋巴瘤(PCNSL)是一种较少见的中枢神经系统恶性肿瘤,总体预后欠佳,主要治疗方法包括手术、放疗和化疗.立体定向活检术以其微创、便捷的优点,已经成为确诊PCNSL的常规方法.全脑放疗是多病灶性PCNSL的标准化治疗方法,可短期内延缓肿瘤进展.以大剂量甲氨蝶呤为基础的治疗方案大大改善了PCNSL的治疗效果,成为PCNSL的有效治疗措施.有效的综合治疗是延长PCNSL患者生存期和改善生命质量的关键. As a kind of rare central nervous system malignant tumor, primary central nervous system lymphoma (PCNSL) has poor prognosis, and the main treatment include surgery, radiotherapy and chemotherapy.Stereotactic biopsy has become a routine diagnostic method of PCNSL, because of which has the advantage of minimally invasive and convenient.Whole brain radiotherapy is a standardized treatment method for the multifocal PCNSL, which can delay the progress of tumor in a short term.The therapeutic regimen based on high dose methotrexate leads to significant changes in the PCNSL treatment and it has become an effective treatment measure.Effective comprehensive treatment is the key to extending survival time and improving the quality of life for the patients with PCNSL.
出处 《国际肿瘤学杂志》 CAS 2016年第1期71-74,共4页 Journal of International Oncology
关键词 淋巴瘤 中枢神经系统肿瘤 放射疗法 药物疗法 甲氨蝶呤 Lymphoma Central nervous system neoplasms Radiotherapy Drug therapy Methotrexate
  • 相关文献

参考文献4

二级参考文献33

  • 1于同刚,戴嘉中,冯晓源.原发性中枢神经系统淋巴瘤的MRI及^1H-MRS特点[J].临床放射学杂志,2005,24(8):668-672. 被引量:64
  • 2Abrey LE Batchelor TT Ferreri A J Gospodarowicz M Pulczynski EJ Zucca E Smith JR Korfel A Soussain C DeAngelis LM Neuwelt EA O′Neill BP Thiel E Shenkier T Graus F van den Bent M Seymour JF Poortmans P Armitage JO Cavalli F.Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.[J].中国神经肿瘤杂志,2005,3(3):182-182. 被引量:61
  • 3Muta D, Makino K, Nakamura H, et al. Inhibition of eIF4E phosphorylation reduces cell growth and proliferation in primary central nervous system lymphoma cells. J Neurooncol, 2011, 101 : 33-39.
  • 4Chimienti E, Spina M, Vaccher E, et al. Management of immunocompetent patients with primary central nervous system lymphoma. Clin Lymphoma Myeloma, 2009, 9:353-364.
  • 5Schultz C J, Bovi J. Current management of primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys, 2010, 76 : 666 -678.
  • 6Usui N, Dobashi N, Yano S, et al. High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute. Gan To Kagaku Ryuho, 2010, 37:1277-1282.
  • 7Bellinzona M, Roser F, Ostertag H, et al. Surgical removal of primary central neJ'vous system lymphomas (PCNSL) presenting asspace occupying lesions : a series of 33 cases. Eur J Surg Oncol, 2005, 31:100-105.
  • 8Angelov L, Dootittle ND, Kraemer DF, et al. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol, 2009, 27:3503-3509.
  • 9Sierra del Rio M, Rousseau A, Soussain C, et al. Primary CNS lymphoma in immunocompetent patients. Oncologist, 2009,14: 526-539.
  • 10Gerstner ER, Carson KA, Grossman SA, et al. Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology, 2008, 70:401-402.

共引文献17

同被引文献30

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部